IOVA icon

Iovance Biotherapeutics
IOVA

Overview Fund Activity

232 hedge funds and large institutions have $4.22B invested in Iovance Biotherapeutics in 2021 Q2 according to their latest regulatory filings, with 45 funds opening new positions, 101 increasing their positions, 56 reducing their positions, and 62 closing their positions.

Holders
232
Holders Change
-18
Holders Change %
-7.2%
% of All Funds
4.05%
Holding in Top 10
7
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.12%
New
45
Increased
101
Reduced
56
Closed
62
Calls
$77.1M
Puts
$36.5M
Net Calls
+$40.6M
Net Calls Change
+$21.7M

Top Buyers

1
AC
1
Armistice Capital
New York
$87.7M
2
Sumitomo Mitsui Trust Group
2
Sumitomo Mitsui Trust Group
Japan
$201M
3
NAMA
3
Nikko Asset Management Americas
New York
$199M
4
PA
4
Perceptive Advisors
New York
$285M
5
Fidelity Investments
5
Fidelity Investments
Massachusetts
$69.7M

Top Sellers

1
Deutsche Bank
1
Deutsche Bank
Germany
$188K
2
AllianceBernstein
2
AllianceBernstein
Tennessee
$2.83M
3
BlackRock
3
BlackRock
New York
$176M
4
Bank of America
4
Bank of America
North Carolina
$12M
5
Franklin Resources
5
Franklin Resources
California
$188M
Name Market Value Shares Shares
Change 		Shares
Change %
AIM
1
ARK Investment Management
Florida
$480M 18,450,713 -1,275,937 -6%
Vanguard Group
2
Vanguard Group
Pennsylvania
$318M 12,236,411 +182,924 +2%
PA
3
Perceptive Advisors
New York
$285M 10,959,772 +2,307,987 +27%
ACA
4
Avoro Capital Advisors
New York
$237M 9,100,000 +1,100,000 +14%
Sumitomo Mitsui Trust Group
5
Sumitomo Mitsui Trust Group
Japan
$201M 7,737,618 +2,434,885 +46%
NAMA
6
Nikko Asset Management Americas
New York
$199M 7,724,788 +2,378,927 +45%
Wellington Management Group
7
Wellington Management Group
Massachusetts
$189M 7,251,243 +3,586 +0%
Franklin Resources
8
Franklin Resources
California
$188M 7,227,073 -1,783,897 -20%
BlackRock
9
BlackRock
New York
$176M 6,768,169 -2,206,646 -25%
O
10
OrbiMed
New York
$173M 6,645,100 – –
FCM
11
Farallon Capital Management
California
$137M 5,250,000 +500,000 +11%
T. Rowe Price Associates
12
T. Rowe Price Associates
Maryland
$121M 4,650,552 -484,904 -9%
State Street
13
State Street
Massachusetts
$103M 3,942,673 +867,022 +28%
AC
14
Armistice Capital
New York
$87.7M 3,372,000 +3,372,000 New
Artisan Partners
15
Artisan Partners
Wisconsin
$77.4M 2,974,334 -8,780 -0.3%
Fidelity Investments
16
Fidelity Investments
Massachusetts
$69.7M 2,678,159 +1,704,784 +175%
CS
17
Credit Suisse
Switzerland
$62.8M 2,412,203 +17,714 +0.7%
Citadel Advisors
18
Citadel Advisors
Florida
$61.9M 2,377,664 +1,621,945 +215%
FM
19
Frazier Management
Washington
$55.6M 2,137,999 +825,000 +63%
Geode Capital Management
20
Geode Capital Management
Massachusetts
$47.6M 1,829,236 +106,413 +6%
Bank of New York Mellon
21
Bank of New York Mellon
New York
$45.3M 1,739,775 +231,203 +15%
Goldman Sachs
22
Goldman Sachs
New York
$42.7M 1,642,578 -274,931 -14%
Assenagon Asset Management
23
Assenagon Asset Management
Luxembourg
$38.5M 1,479,719 +1,443,340 +3,968%
JPMorgan Chase & Co
24
JPMorgan Chase & Co
New York
$36.8M 1,415,007 +72,198 +5%
Ameriprise
25
Ameriprise
Minnesota
$33.5M 1,286,447 +832,124 +183%
1
2 3 4 5